Format

Send to

Choose Destination
PLoS One. 2013 Sep 30;8(9):e76774. doi: 10.1371/journal.pone.0076774. eCollection 2013.

MIP-2A is a novel target of an anilinoquinazoline derivative for inhibition of tumour cell proliferation.

Author information

1
Department of Biosciences and Informatics, Keio University, Yokohama, Japan.

Abstract

We recently identified a novel anilinoquinazoline derivative, Q15, as a potent apoptosis inducer in a panel of human cancer cell lines and determined that Q15 targets hCAP-G2, a subunit of condensin II complex, leading to abnormal cell division. However, whether the defect in normal cell division directly results in cell death remains unclear. Here, we used an mRNA display method on a microfluidic chip to search for other Q15-binding proteins. We identified an additional Q15-binding protein, MIP-2A (MBP-1 interacting protein-2A), which has been reported to interact with MBP-1, a repressor of the c-Myc promoter. Our results indicate that Q15 inhibits the interaction between MIP-2A and MBP-1 as well as the expression of c-Myc protein, thereby inducing cell death. This study suggests that the simultaneous targeting of hCAP-G2 and MIP-2A is a promising strategy for the development of antitumor drugs as a treatment for intractable tumours.

PMID:
24098805
PMCID:
PMC3786957
DOI:
10.1371/journal.pone.0076774
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center